US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quantum Biopharma Ltd.

3.78

+0.13003.56%

Volume:160.21K

Turnover:607.94K

Market Cap:30.57M

PE:-0.71

High:3.88

Open:3.63

Low:3.63

Close:3.65

52wk High:21.00

52wk Low:2.07

Shares:8.09M

Float Shares:7.65M

Volume Ratio:1.16

T/O Rate:2.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.3537

EPS(LYR):-7.9660

ROE:-621.46%

ROA:-51.84%

PB:3.85

PE(LYR):-0.47

Loading ...

Overview Company News Filings

Quantum BioPharma (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiates Coverage with Buy Rating, $8 Price Target

Rodman & Renshaw Initiates Quantum BioPharma Coverage with Buy Rating, US$ 8 Target

Quantum BioPharma (NASDAQ: QNTM) to Present at 3rd Annual ArcStone-Kingswood Growth Summit

Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto

Stray Alert on Quantum BioPharma Withdrawn

Networknewsaudio Announces Audio Press Release (Apr) Discussing FDA Clearance for Trial of First-in-Class Treatment Creating ‘Rare Moment’ in MS Research

THOMSON REUTERS

Quantum BioPharma Wins FDA Clearance for Lucid-MS Phase 2 Trial

Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment

Quantum Biopharma Amends Form 6-K to Add Exhibit to F-3 Registration Statement

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Draws ‘Buy’ Rating on Lucid-MS Potential

Quantum Biopharma Provides Corporate Update

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves

Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rates in Multiple Sclerosis

Quantum Biopharma Ltd Expected to Post a Loss of 42 Cents a Share - Earnings Preview

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances MS Imaging Study with Encouraging Preliminary Results

Quantum Biopharma Ltd Expected to Post a Loss of 42 Cents a Share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/QNTM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"QNTM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNTM\",,,,,undefined,":{"symbol":"QNTM","market":"US","secType":"STK","nameCN":"Quantum Biopharma Ltd.","latestPrice":3.78,"timestamp":1789669185503,"preClose":3.65,"halted":0,"volume":160214,"delay":0,"changeRate":0.035616438356164355,"floatShares":7650300,"shares":8087521,"eps":-5.353747,"marketStatus":"Trading","change":0.13,"latestTime":"09-17 14:23:05 EDT","open":3.63,"high":3.88,"low":3.63,"amount":607943.558408,"amplitude":0.068493,"askPrice":3.8,"askSize":2944,"bidPrice":3.74,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-5.353747,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":3.65,"preHourTrading":{"tag":"盘前","latestPrice":3.6757,"preClose":3.65,"latestTime":"09:22 EDT","volume":5326,"amount":19700.63433,"timestamp":1789651360945,"change":0.0257,"changeRate":0.007041,"amplitude":0.090329},"postHourTrading":{"tag":"盘后","latestPrice":3.5896,"preClose":3.65,"latestTime":"19:30 EDT","volume":6178,"amount":22135.9684,"timestamp":1789601405304,"change":-0.0604,"changeRate":-0.016548,"amplitude":0.019178},"volumeRatio":1.158781},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNTM\",,,,,undefined,":{"symbol":"QNTM","floatShares":7650300,"roa":"-51.84%","roe":"-621.46%","lyrEps":-7.965999,"volumeRatio":1.158781,"shares":8087521,"dividePrice":0,"high":3.88,"amplitude":0.068493,"preClose":3.65,"low":3.63,"week52Low":2.07,"pbRate":"3.85","week52High":21,"institutionHeld":0,"latestPrice":3.78,"committee":-0.934297,"eps":-5.353747,"divideRate":0,"volume":160214,"delay":0,"ttmEps":-5.353747,"open":3.63,"prevYearClose":7.3,"prevWeekClose":3.2,"prevMonthClose":3.17,"prevQuarterClose":3.62,"fiveDayClose":3.29,"twentyDayClose":3.52,"sixtyDayClose":3.85},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QNTM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"QNTM","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.47},{"market":"US","date":"2026-05-06","symbol":"QNTM","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":-3.06},{"date":"2026-03-24","symbol":"QNTM","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774382400000,"name":null,"time":"Post-Mkt","dateTimestamp":1774324800000,"actualEps":null},{"market":"US","date":"2024-08-15","symbol":"QNTM","defaultRemindTime":1723728600000,"type":"split","dateTimestamp":1723694400000,"forFactor":65,"toFactor":1,"ratio":65},{"market":"US","date":"2024-08-14","symbol":"QNTM","fiscalQuarterEnding":"2024/06","expectedEps":-0.06,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QNTM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QNTM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1756526400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QNTM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QNTM","date":"2026-09-16","current":-0.706048,"percent":0.460501,"low":-5.103283,"twenty":-1.986478,"median":-1.047426,"eighty":-0.706351,"high":-0.282397,"avg":-1.35082,"sd":0.868343,"marketCap":27982822},"quantilePoints":[{"date":"2024-08-16","current":-0.603659,"twenty":-0.603659,"median":-0.603659,"eighty":-0.603659,"marketCap":4509122.69},{"date":"2024-08-23","current":-0.69618,"twenty":-0.715087,"median":-0.702389,"eighty":-0.647248,"marketCap":5200216.8},{"date":"2024-08-30","current":-0.852638,"twenty":-0.775012,"median":-0.723053,"eighty":-0.69618,"marketCap":6368904.17},{"date":"2024-09-06","current":-0.700453,"twenty":-0.779153,"median":-0.715087,"eighty":-0.653758,"marketCap":5232131.53},{"date":"2024-09-13","current":-0.690425,"twenty":-0.744955,"median":-0.704525,"eighty":-0.66483,"marketCap":5157233.86},{"date":"2024-09-20","current":-0.993485,"twenty":-0.779153,"median":-0.708429,"eighty":-0.669437,"marketCap":7420982.26},{"date":"2024-09-27","current":-0.939399,"twenty":-0.944216,"median":-0.716816,"eighty":-0.671749,"marketCap":7016975.73},{"date":"2024-10-04","current":-0.974979,"twenty":-0.964556,"median":-0.73591,"eighty":-0.672431,"marketCap":7282751.47},{"date":"2024-10-11","current":-1.090369,"twenty":-0.996068,"median":-0.785363,"eighty":-0.686838,"marketCap":8144673.49},{"date":"2024-10-18","current":-1.45785,"twenty":-1.05098,"median":-0.878475,"eighty":-0.692178,"marketCap":10889624.45},{"date":"2024-10-25","current":-1.442036,"twenty":-1.139524,"median":-0.944288,"eighty":-0.695467,"marketCap":10771499.96},{"date":"2024-10-31","current":-1.205452,"twenty":-1.188827,"median":-0.956387,"eighty":-0.698744,"marketCap":9004299.96},{"date":"2024-11-08","current":-1.349307,"twenty":-1.226202,"median":-0.974979,"eighty":-0.705239,"marketCap":10078847.03},{"date":"2024-11-15","current":-0.935735,"twenty":-1.275577,"median":-0.971909,"eighty":-0.70853,"marketCap":9579098.88},{"date":"2024-11-22","current":-0.960529,"twenty":-1.226202,"median":-0.963485,"eighty":-0.712491,"marketCap":9832911.8},{"date":"2024-11-29","current":-0.869873,"twenty":-1.213599,"median":-0.963485,"eighty":-0.716471,"marketCap":8904877.06},{"date":"2024-12-06","current":-0.815226,"twenty":-1.195279,"median":-0.949234,"eighty":-0.720349,"marketCap":8345447.87},{"date":"2024-12-13","current":-0.759973,"twenty":-1.179109,"median":-0.943869,"eighty":-0.728196,"marketCap":7779827.58},{"date":"2024-12-20","current":-0.685739,"twenty":-1.175332,"median":-0.939333,"eighty":-0.720349,"marketCap":7019890.91},{"date":"2024-12-27","current":-0.616825,"twenty":-1.165719,"median":-0.934788,"eighty":-0.708463,"marketCap":6314424.32},{"date":"2025-01-03","current":-0.759721,"twenty":-1.141743,"median":-0.927085,"eighty":-0.708429,"marketCap":7777249.84},{"date":"2025-01-10","current":-0.742133,"twenty":-1.141141,"median":-0.878991,"eighty":-0.708564,"marketCap":7597197.4},{"date":"2025-01-17","current":-0.619978,"twenty":-1.139524,"median":-0.852638,"eighty":-0.692178,"marketCap":6346706.26},{"date":"2025-01-24","current":-0.619485,"twenty":-1.109884,"median":-0.815226,"eighty":-0.676014,"marketCap":6341654.9},{"date":"2025-01-31","current":-0.561714,"twenty":-1.082749,"median":-0.80554,"eighty":-0.668876,"marketCap":5750259.21},{"date":"2025-02-07","current":-2.690643,"twenty":-1.13989,"median":-0.808855,"eighty":-0.664161,"marketCap":27544054.02},{"date":"2025-02-14","current":-1.986183,"twenty":-1.178654,"median":-0.820792,"eighty":-0.668876,"marketCap":20332510.29},{"date":"2025-02-21","current":-1.288506,"twenty":-1.229787,"median":-0.861255,"eighty":-0.670874,"marketCap":13190405.23},{"date":"2025-02-28","current":-0.926203,"twenty":-1.213599,"median":-0.879508,"eighty":-0.672308,"marketCap":9481520.11},{"date":"2025-03-07","current":-0.836122,"twenty":-1.195279,"median":-0.874174,"eighty":-0.673618,"marketCap":8559365.07},{"date":"2025-03-14","current":-0.835912,"twenty":-1.179109,"median":-0.852638,"eighty":-0.675778,"marketCap":8557218.89},{"date":"2025-03-21","current":-1.273806,"twenty":-1.21489,"median":-0.874174,"eighty":-0.680186,"marketCap":13039931.07},{"date":"2025-03-28","current":-1.564993,"twenty":-1.229787,"median":-0.90884,"eighty":-0.687613,"marketCap":16020800.96},{"date":"2025-04-04","current":-1.52667,"twenty":-1.237788,"median":-0.92592,"eighty":-0.691301,"marketCap":21682873.03},{"date":"2025-04-11","current":-1.273742,"twenty":-1.263262,"median":-0.933841,"eighty":-0.694042,"marketCap":18090602.39},{"date":"2025-04-17","current":-1.168311,"twenty":-1.270743,"median":-0.939267,"eighty":-0.697035,"marketCap":16593197.2},{"date":"2025-04-25","current":-1.303484,"twenty":-1.273793,"median":-0.943051,"eighty":-0.702048,"marketCap":18513021.69},{"date":"2025-05-02","current":-1.294143,"twenty":-1.300404,"median":-0.949177,"eighty":-0.708463,"marketCap":18380352.73},{"date":"2025-05-09","current":-1.644919,"twenty":-1.308736,"median":-0.962007,"eighty":-0.709896,"marketCap":23362327.89},{"date":"2025-05-16","current":-1.199271,"twenty":-1.337538,"median":-0.972354,"eighty":-0.715779,"marketCap":25036080.26},{"date":"2025-05-23","current":-1.700878,"twenty":-1.355009,"median":-0.987733,"eighty":-0.719447,"marketCap":35507635.07},{"date":"2025-05-30","current":-1.849192,"twenty":-1.384044,"median":-0.999942,"eighty":-0.723053,"marketCap":38603856.21},{"date":"2025-06-06","current":-1.987659,"twenty":-1.412213,"median":-1.024718,"eighty":-0.730988,"marketCap":41494516.93},{"date":"2025-06-13","current":-2.785039,"twenty":-1.45785,"median":-1.044309,"eighty":-0.732179,"marketCap":58140674.16},{"date":"2025-06-20","current":-4.672124,"twenty":-1.533455,"median":-1.053859,"eighty":-0.735164,"marketCap":97535599.55},{"date":"2025-06-27","current":-3.063611,"twenty":-1.577606,"median":-1.066156,"eighty":-0.737135,"marketCap":63956175.36},{"date":"2025-07-03","current":-3.024954,"twenty":-1.604449,"median":-1.085482,"eighty":-0.740256,"marketCap":63149159.33},{"date":"2025-07-11","current":-3.084976,"twenty":-1.659316,"median":-1.102079,"eighty":-0.743302,"marketCap":64402188.5},{"date":"2025-07-18","current":-3.697095,"twenty":-1.697935,"median":-1.139157,"eighty":-0.750417,"marketCap":77180813.38},{"date":"2025-07-25","current":-3.903987,"twenty":-1.729557,"median":-1.145237,"eighty":-0.755282,"marketCap":81499908.28},{"date":"2025-08-01","current":-3.850248,"twenty":-1.976604,"median":-1.168311,"eighty":-0.756432,"marketCap":80378057.01},{"date":"2025-08-08","current":-3.251562,"twenty":-2.145068,"median":-1.17213,"eighty":-0.758598,"marketCap":87848173.72},{"date":"2025-08-15","current":-3.198407,"twenty":-2.206312,"median":-1.180019,"eighty":-0.759872,"marketCap":86412082.96},{"date":"2025-08-22","current":-2.566662,"twenty":-2.295093,"median":-1.200668,"eighty":-0.76105,"marketCap":69344082.91},{"date":"2025-08-29","current":-2.463142,"twenty":-2.498451,"median":-1.205452,"eighty":-0.767064,"marketCap":66547249.25},{"date":"2025-09-05","current":-2.044999,"twenty":-2.440845,"median":-1.20871,"eighty":-0.77135,"marketCap":55250186.41},{"date":"2025-09-12","current":-2.246031,"twenty":-2.40096,"median":-1.237649,"eighty":-0.773496,"marketCap":60681519.12},{"date":"2025-09-19","current":-2.839836,"twenty":-2.455251,"median":-1.247543,"eighty":-0.776011,"marketCap":76724478.13},{"date":"2025-09-26","current":-2.458995,"twenty":-2.54398,"median":-1.273774,"eighty":-0.779832,"marketCap":66435214.85},{"date":"2025-10-03","current":-2.626987,"twenty":-2.54398,"median":-1.294143,"eighty":-0.784514,"marketCap":70973899.18},{"date":"2025-10-10","current":-2.192104,"twenty":-2.54398,"median":-1.303484,"eighty":-0.790074,"marketCap":59224574.82},{"date":"2025-10-17","current":-2.092104,"twenty":-2.522921,"median":-1.31003,"eighty":-0.798319,"marketCap":56522834.81},{"date":"2025-10-24","current":-1.998894,"twenty":-2.490093,"median":-1.336026,"eighty":-0.804877,"marketCap":54004551.85},{"date":"2025-10-31","current":-1.717731,"twenty":-2.461483,"median":-1.349307,"eighty":-0.809547,"marketCap":46408334.29},{"date":"2025-11-07","current":-1.214307,"twenty":-2.456967,"median":-1.346562,"eighty":-0.811449,"marketCap":32807200.11},{"date":"2025-11-14","current":-0.999408,"twenty":-2.449721,"median":-1.333506,"eighty":-0.812764,"marketCap":28492214.92},{"date":"2025-11-21","current":-0.809452,"twenty":-2.443032,"median":-1.306795,"eighty":-0.812764,"marketCap":23076724.76},{"date":"2025-11-28","current":-1.99435,"twenty":-2.440993,"median":-1.303521,"eighty":-0.812755,"marketCap":56857092.25},{"date":"2025-12-05","current":-1.323967,"twenty":-2.429584,"median":-1.303559,"eighty":-0.813277,"marketCap":37745076.44},{"date":"2025-12-12","current":-1.335992,"twenty":-2.40418,"median":-1.312104,"eighty":-0.817452,"marketCap":38087887.17},{"date":"2025-12-19","current":-1.198571,"twenty":-2.388895,"median":-1.303559,"eighty":-0.828269,"marketCap":34170142.64},{"date":"2025-12-26","current":-1.17466,"twenty":-2.379275,"median":-1.303559,"eighty":-0.835912,"marketCap":33488470.85},{"date":"2026-01-02","current":-1.024308,"twenty":-2.374773,"median":-1.303484,"eighty":-0.83608,"marketCap":29202064.92},{"date":"2026-01-09","current":-1.024342,"twenty":-2.370202,"median":-1.297534,"eighty":-0.836442,"marketCap":29203060.66},{"date":"2026-01-16","current":-0.962306,"twenty":-2.365011,"median":-1.273806,"eighty":-0.836933,"marketCap":27434474.15},{"date":"2026-01-23","current":-0.818739,"twenty":-2.35393,"median":-1.258745,"eighty":-0.83683,"marketCap":23341480.01},{"date":"2026-01-30","current":-0.646874,"twenty":-2.338922,"median":-1.240166,"eighty":-0.83209,"marketCap":18441780.68},{"date":"2026-02-06","current":-0.51617,"twenty":-2.313051,"median":-1.238341,"eighty":-0.812772,"marketCap":14715534.29},{"date":"2026-02-13","current":-0.48348,"twenty":-2.289085,"median":-1.227163,"eighty":-0.806203,"marketCap":13783564.41},{"date":"2026-02-20","current":-0.510955,"twenty":-2.277113,"median":-1.211508,"eighty":-0.784514,"marketCap":14566867.56},{"date":"2026-02-27","current":-0.482735,"twenty":-2.268051,"median":-1.205452,"eighty":-0.77135,"marketCap":13762327.04},{"date":"2026-03-06","current":-0.480638,"twenty":-2.260327,"median":-1.201217,"eighty":-0.759822,"marketCap":13702547.29},{"date":"2026-03-13","current":-0.345591,"twenty":-2.251574,"median":-1.198571,"eighty":-0.748305,"marketCap":9852486.38},{"date":"2026-03-20","current":-0.311897,"twenty":-2.250177,"median":-1.193253,"eighty":-0.733671,"marketCap":8891895.03},{"date":"2026-03-27","current":-0.777682,"twenty":-2.248085,"median":-1.177744,"eighty":-0.727951,"marketCap":22171007.34},{"date":"2026-04-02","current":-0.966895,"twenty":-2.243786,"median":-1.17466,"eighty":-0.731226,"marketCap":25308745.18},{"date":"2026-04-10","current":-0.724897,"twenty":-2.230428,"median":-1.171167,"eighty":-0.731226,"marketCap":18974373.59},{"date":"2026-04-17","current":-0.69348,"twenty":-2.210721,"median":-1.156871,"eighty":-0.725103,"marketCap":18152022.61},{"date":"2026-04-24","current":-0.70644,"twenty":-2.200145,"median":-1.149008,"eighty":-0.719447,"marketCap":18491265.64},{"date":"2026-05-01","current":-1.276112,"twenty":-2.19291,"median":-1.149285,"eighty":-0.723422,"marketCap":33402585.18},{"date":"2026-05-08","current":-0.954696,"twenty":-2.190798,"median":-1.156487,"eighty":-0.725103,"marketCap":29747253.42},{"date":"2026-05-15","current":-1.294148,"twenty":-2.18434,"median":-1.149285,"eighty":-0.726938,"marketCap":40324190.28},{"date":"2026-05-22","current":-1.4357,"twenty":-2.174869,"median":-1.159132,"eighty":-0.731226,"marketCap":44734793.46},{"date":"2026-05-29","current":-1.450346,"twenty":-2.156767,"median":-1.169466,"eighty":-0.732179,"marketCap":45191130.81},{"date":"2026-06-05","current":-0.921778,"twenty":-2.137268,"median":-1.161393,"eighty":-0.73591,"marketCap":28721555.07},{"date":"2026-06-12","current":-0.810905,"twenty":-2.112799,"median":-1.152694,"eighty":-0.737441,"marketCap":25266894.45},{"date":"2026-06-18","current":-0.829635,"twenty":-2.112336,"median":-1.145237,"eighty":-0.737135,"marketCap":25850466.62},{"date":"2026-06-26","current":-0.810281,"twenty":-2.096127,"median":-1.139157,"eighty":-0.739986,"marketCap":25247435.62},{"date":"2026-07-02","current":-0.745531,"twenty":-2.073087,"median":-1.12168,"eighty":-0.741529,"marketCap":23229917.66},{"date":"2026-07-10","current":-0.697216,"twenty":-2.057059,"median":-1.110604,"eighty":-0.732083,"marketCap":21724470.61},{"date":"2026-07-17","current":-0.694802,"twenty":-2.052904,"median":-1.089963,"eighty":-0.725514,"marketCap":21649231.79},{"date":"2026-07-24","current":-0.582883,"twenty":-2.047649,"median":-1.086241,"eighty":-0.712491,"marketCap":18161979.51},{"date":"2026-07-31","current":-0.586219,"twenty":-2.039494,"median":-1.077144,"eighty":-0.706418,"marketCap":18265931.12},{"date":"2026-08-07","current":-0.643895,"twenty":-2.019939,"median":-1.058772,"eighty":-0.699237,"marketCap":20063028.05},{"date":"2026-08-14","current":-0.664353,"twenty":-2.001353,"median":-1.053767,"eighty":-0.699237,"marketCap":20700464.83},{"date":"2026-08-21","current":-1.120238,"twenty":-1.997627,"median":-1.050246,"eighty":-0.70102,"marketCap":28183811.41},{"date":"2026-08-28","current":-0.983205,"twenty":-1.995176,"median":-1.049639,"eighty":-0.702964,"marketCap":24736226.71},{"date":"2026-09-04","current":-0.955906,"twenty":-1.991674,"median":-1.04213,"eighty":-0.70522,"marketCap":24049403.1},{"date":"2026-09-11","current":-1.057601,"twenty":-1.987364,"median":-1.045821,"eighty":-0.706197,"marketCap":26607944},{"date":"2026-09-16","current":-1.11225,"twenty":-1.986478,"median":-1.047426,"eighty":-0.706351,"marketCap":27982822}],"updateTime":1789669385325},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QNTM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668993499","title":"Quantum BioPharma (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiates Coverage with Buy Rating, $8 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2668993499","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668993499?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662616,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 17th, 2026, FinanceWire Disseminated on behalf of Quantum BioPharma Ltd. and may include pai...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-announces-that-rodman-renshaw-initiates-coverage-with-buy-rating-8-price-target?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-announces-that-rodman-renshaw-initiates-coverage-with-buy-rating-8-price-target?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNTM",".IXIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668964186","title":"Rodman & Renshaw Initiates Quantum BioPharma Coverage with Buy Rating, US$ 8 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2668964186","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668964186?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:01","pubTimestamp":1789646497,"startTime":"0","endTime":"0","summary":"Rodman & Renshaw initiates Quantum BioPharma coverage with buy rating, US$ 8 targetRodman & Renshaw initiated coverage of Quantum BioPharma with a Buy rating.The firm set a US$ 8 price target.Coverage","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL4Pg746:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","LU2210150020.SGD","BK4588","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","BK4007","LU0314104364.USD","IE00BQXX3C00.GBP","BK4112","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","IE00BQXX3F31.USD","QNTM","LU2095319765.USD","IE00BN0W2V16.EUR","SG9999014021.USD","LU2210149790.SGD","BCDF","SG9999014013.SGD","IE00BN0W2W23.USD","BK4585","IE00B3QW5Z07.USD","SG9999014039.USD","NDAQ","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667268946","title":"Quantum BioPharma (NASDAQ: QNTM) to Present at 3rd Annual ArcStone-Kingswood Growth Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2667268946","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667268946?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488029,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 15th, 2026, FinanceWire Disseminated on behalf of Quantum BioPharma Ltd. and may include pai...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-to-present-at-3rd-annual-arcstone-kingswood-growth-summit?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-to-present-at-3rd-annual-arcstone-kingswood-growth-summit?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":[".IXIC","NQmain","03086","QQQ","NDX","BK4007","MNQmain","GPIQ","JEPQ","ONEQ","QQQM","QLD","FTEC","TQQY","TQQQ","QDTE","QQQA","TECS","PSQ","QNTM","QQQE","SQQQ","QID","QQQY","QYLG","QQQJ","IYW","NVIW.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642172","title":"Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642172","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642172?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473600,"startTime":"0","endTime":"0","summary":"TORONTO, Sept.  15, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FSE: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362028/0/en/quantum-biopharma-to-attend-the-arcstone-kingswood-growth-summit-2026-in-toronto.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875169.SGD","BK4588","KBWB","LU1064131342.USD","LU2487616109.SGD","BK4127","LU2347655156.SGD","LU2357305700.SGD","LCID","LU0106831901.USD","LU0210528500.USD","LU1989772923.USD","LU0053666078.USD","LU2089284900.SGD","LU0882574139.USD","IAI","LU1791710582.SGD","IE00B775SV38.USD","LU1244550221.USD","LU0557290698.USD","BK4007","LU0158827948.USD","LU2264538146.SGD","BK4516","LU1244550494.USD","LU1988902786.USD","LU0225283273.USD","LU2111349929.HKD","LU0098860793.USD","LU1720051017.SGD","LU0971096721.USD","LCDL","BK4534","LU2089283258.USD","BK4555","LCIZ","LU0390134368.USD","LU1074936037.SGD","LU2023251221.USD","LU0267386448.USD","BK4504","QNTM","LU1668664300.SGD","LU1732799900.SGD","IE00B3S45H60.SGD","LU0528227936.USD","LU1548497426.USD","BK4585","LU2133065610.SGD","LU1162221912.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666161","title":"Stray Alert on Quantum BioPharma Withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666161","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666161?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:47","pubTimestamp":1789390050,"startTime":"0","endTime":"0","summary":"ADVISORY-Stray alert on Quantum BioPharma withdrawnAn alert from NetworkNewsAudio announcing an audio press release about FDA clearance of a clinical trial involving Quantum BioPharma was inadvertentl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA2MG65F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","QNTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667665723","title":"Networknewsaudio Announces Audio Press Release (Apr) Discussing FDA Clearance for Trial of First-in-Class Treatment Creating ‘Rare Moment’ in MS Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2667665723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667665723?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:30","pubTimestamp":1789389001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA2MG65F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","QNTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666524435","title":"Quantum BioPharma Wins FDA Clearance for Lucid-MS Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2666524435","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666524435?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:30","pubTimestamp":1789129845,"startTime":"0","endTime":"0","summary":"Quantum BioPharma wins FDA clearance for Lucid-MS Phase 2 trialQuantum BioPharma secured FDA clearance to start a Phase 2 trial of Lucid-MS in multiple sclerosis.Lucid-MS targets protection or potenti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL3nwWkk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","QNTM","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","SG9999014013.SGD","LU2210149790.SGD","BK4585","IE00BN0W2W23.USD","SG9999014039.USD","BCDF","SG9999014005.SGD","BK4588","SG9999014021.USD","BK4112","IE00BN0W2V16.EUR","NDAQ","LU0314104364.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666524717","title":"Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2666524717","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666524717?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:30","pubTimestamp":1789129800,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  11, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd.(NASDAQ: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands withi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/11/3360308/0/en/quantum-biopharma-ltd-nasdaq-qntm-filling-key-gap-in-ms-treatment-cleared-by-fda-to-launch-historic-trials.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYW","QQQM","BK4099","TQQY","GPIQ","QQQ","QNTM","TM","MNQmain","JEPQ","QDTE","QYLG","03160","BK4007","QLD","NDX","SQQQ","PSQ","BK4604","QQQA","FTEC","TECS",".IXIC","NQmain","QQQY","LABU","BK4585","BK4555","ONEQ","QQQE","QQQJ","03086","NVIW.SI","QID","TQQQ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666970533","title":"Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666970533","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666970533?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:30","pubTimestamp":1788957000,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  09, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd.(NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358646/0/en/quantum-biopharma-ltd-nasdaq-qntm-receives-fda-clearance-to-begin-trials-for-historic-ms-treatment.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQE","NVIW.SI","JEPQ","SQQQ","QLD","NQmain","GPIQ","IYW","QQQ","BK4604","BK4007","LABU","BK4099","BK4555","QQQJ","BK4585","QQQY","03160","03086","BK4588","TECS","TQQQ","NDX","QYLG","MNQmain","FTEC","TQQY","QID","QQQM","QDTE","TM","ONEQ","QNTM","QQQA",".IXIC","PSQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371438","title":"Quantum Biopharma Amends Form 6-K to Add Exhibit to F-3 Registration Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371438?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:39","pubTimestamp":1788885550,"startTime":"0","endTime":"0","summary":"Quantum Biopharma amends Form 6-K to add exhibit to F-3 registration statementQuantum Biopharma filed an amended Form 6-K to update its earlier March 30, 2026 report.Amendment incorporated a previousl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1rcQ0T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNTM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664035002","title":"Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Draws ‘Buy’ Rating on Lucid-MS Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2664035002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664035002?lang=en_us&edition=fundamental","pubTime":"2026-09-01 00:30","pubTimestamp":1788193807,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, August 31st, 2026, FinanceWire Disseminated on behalf of Quantum BioPharma Ltd. and may include paid a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-cse-qntm-draws-buy-rating-on-lucid-ms-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-cse-qntm-draws-buy-rating-on-lucid-ms-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCID","QNTM",".IXIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661213351","title":"Quantum Biopharma Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213351","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213351?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:00","pubTimestamp":1787353200,"startTime":"0","endTime":"0","summary":"THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, Aug.  21, 2026 (GL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/21/3349353/0/en/quantum-biopharma-provides-corporate-update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","QNTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660356632","title":"Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves","url":"https://stock-news.laohu8.com/highlight/detail?id=2660356632","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660356632?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:30","pubTimestamp":1787239824,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, August 20th, 2026, FinanceWire This article has been disseminated on behalf of Quantum BioPharma Ltd. and m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-cse-qntm-advances-myelin-protecting-ms-therapy-as-treatment-paradigm-evolves?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-cse-qntm-advances-myelin-protecting-ms-therapy-as-treatment-paradigm-evolves?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNQmain","IYW","QDTE","JEPQ","LU0006306889.USD","QYLG","LU1548497426.USD","NVIW.SI","QQQA","QQQM","IAI","TECS","TQQQ","LU0971096721.USD","BK4127","LU0225283273.USD","NDX","SQQQ","QID","LU1363072403.SGD","FTEC","KBWB","LU2133065610.SGD","LU1668664300.SGD","LU0912757837.SGD","LU0098860793.USD","LU0210528500.USD","LU2028103732.USD","LU1162221912.USD","LU0314104364.USD","ONEQ","QQQY","LU0106261372.USD","PSQ","BK4534","BK4588","BK4516","QQQ","IE00BKVL7J92.USD","LU0106831901.USD","GPIQ","QNTM","QQQE","NQmain",".IXIC","LU0053666078.USD","QLD","LU1791710582.SGD","TQQY","QQQJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145865","title":"Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145865","media":"Dow Jones","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145865?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":"US$9.5 million as of June 30, 2026, increased from US$4.1 million as of. -- Cash and cash equivalents nearly doubled to US$3.65 million, up from. -- Total shareholders' equity increased to US$6.09 million, up approximately. 19% from US$5.10 million at December 31, 2025, reflecting a strengthened. -- Working capital improved significantly to approximately US$1.66 million. as of June 30, 2026, up from approximately US$0.42 million at December. 31, 2025, indicating strengthened short-term liquidity and full coverage. -- Quick ratio of 1.19 as of June 30, 2026, compared to 1.06 as of December. divided by current liabilities), confirming robust liquidity even on a. December 31, 2025. Importantly, approximately 47% of current liabilities,items, reflecting the Company's strong balance sheet management.Reduced Cash Burn and Cost Discipline-- Total operating expenses decreased by 53% in the second quarter of 2026. compared to the same period in 2025, to US$2.29 million from US$4.85. -- General ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0158827948.USD","LU0106261372.USD","KBWB","LABU","LU0098860793.USD","LU0267386448.USD","QNTM","LU0390134368.USD","LU1732799900.SGD","NVIB","BK4099","LU2264538146.SGD","LU0912757837.SGD","LU0210528500.USD","LU0234570918.USD","LU1791710400.SGD","LU1244550577.SGD","LU2111349929.HKD","EQR","IND","BK4596","BK4127","BK4585","VMRK","LU2089283258.USD","IAI","LU2357305700.SGD","LU0795875169.SGD","LCIZ","LU1244550494.USD","LU1988902786.USD","REZ","LU2133065610.SGD","LU0314104364.USD","LCDL","LU0006306889.USD","LU2023251221.USD","03160","LU1732800096.USD","LCID","IE00B775SV38.USD","LU0106831901.USD","LU1989772923.USD","BK4551","LU0053666078.USD","TM","LU1548497426.USD","BK4516","LU1244550221.USD","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659630671","title":"Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rates in Multiple Sclerosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2659630671","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659630671?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:00","pubTimestamp":1786633209,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, August 13th, 2026, FinanceWire This article has been disseminated on behalf of Quantum BioPharma Ltd. and m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-cse-qntm-targets-disability-drivers-beyond-relapse-rates-in-multiple-sclerosis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-cse-qntm-targets-disability-drivers-beyond-relapse-rates-in-multiple-sclerosis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QDTE","QQQM","GPIQ","JEPQ","TECS","QQQ","NVIW.SI","QNTM","QQQE","NQmain","NDX","QLD","SQQQ","QYLG","TQQQ","TQQY",".IXIC","QQQA","FTEC","IYW","PSQ","ONEQ","QQQJ","QID","MNQmain","BK4007","QQQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945966","title":"Quantum Biopharma Ltd Expected to Post a Loss of 42 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945966","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945966?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:48","pubTimestamp":1786481285,"startTime":"0","endTime":"0","summary":"Quantum Biopharma Ltd <QNTM.CD> expected to post a loss of42cents a share - Earnings PreviewQuantum Biopharma LtdQNTM.CDis expected to  show no change in quarterly revenue when it reports  results on August 13  for the period ending June 30 2026LSEG's mean analyst estimate for Quantum Biopharma Ltd is for a loss of 42 cents per share.The one available analyst rating on the shares is \"buy\".The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Quantum Biopharma Ltd is $12.50, about 261.3% above its last closing price of $3.46This summary was machine generated August 11 at 20:48 GMT.  All figures in US dollars unless otherwise stated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N448255:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNTM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658095865","title":"Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2658095865","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658095865?lang=en_us&edition=fundamental","pubTime":"2026-08-11 00:30","pubTimestamp":1786379425,"startTime":"0","endTime":"0","summary":"Toronto, Canada, August 10th, 2026, FinanceWire Paid Advertisement: This article is a paid promotion. Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNT...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-ltd-nasdaq-qntm-cse-qntm-receives-fda-clearance-to-advance-lucid-ms-into-phase-2-multiple-sclerosis-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-ltd-nasdaq-qntm-cse-qntm-receives-fda-clearance-to-advance-lucid-ms-into-phase-2-multiple-sclerosis-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTEC","LU0912757837.SGD","BK4551","LU2347655156.SGD","LU1791710582.SGD","QQQM","QQQJ","QQQ","SQQQ","ONEQ","TQQY","LU1064131342.USD","LU2264538146.SGD","LU2487616109.SGD","LCID","LU1791710400.SGD",".IXIC","TQQQ","LU0225283273.USD","QDTE","LU1720051108.HKD","NDX","IAI","KBWB","QQQA","QID","QYLG","QQQE","IYW","JEPQ","PSQ","NVIW.SI","NQmain","LU0106261372.USD","QQQY","IE00B3S45H60.SGD","LABU","BK4127","LU2028103732.USD","MNQmain","GPIQ","IE00B775SV38.USD","LCIZ","IE00BZ1G4Q59.USD","LU0158827781.USD","LU0320765646.SGD","QLD","QNTM","TECS","LCDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658936984","title":"Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:","url":"https://stock-news.laohu8.com/highlight/detail?id=2658936984","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658936984?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":"Major Regulatory Milestone Positions Company to Initiate Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Patented First-in-Class Neuroprotective Therapy Targeting Demyelination Lucid-MS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/10/3341697/0/en/quantum-biopharma-receives-united-states-fda-clearance-to-proceed-with-lucid-ms-phase-2-trial-in-progressive-multiple-sclerosis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0005OL40V9.USD","LCIZ","KBWP","LU0320765992.SGD","QNTM","LU0070302665.USD","LCID","NBIX","LABU","LU2087625088.SGD","PBE","BIIB","IAI","BK4516","LU1366192091.USD","IAK","LXRX","LU1481011671.HKD","BK4007","LU2065170008.USD","LU1244550221.USD","IE00B775H168.HKD","IE00BN29S564.USD","LU1668664300.SGD","LU0772969993.USD","LU0731783394.SGD","PGR","BMED","BK4139","LU1035773651.USD","CAGR","IE0004445015.USD","BK4099","LU0912757837.SGD","LU1718418525.SGD","LU1988902786.USD","LU0971096721.USD","LU0889565916.HKD","UBCP","IND","IE00BZ1G4Q59.USD","LCDL","NVIB","BK4504","LU2089284900.SGD","BNDI","BK4596","KBWB","LU0053666078.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656649305","title":"Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances MS Imaging Study with Encouraging Preliminary Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2656649305","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656649305?lang=en_us&edition=fundamental","pubTime":"2026-08-04 01:30","pubTimestamp":1785778228,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, August 3rd, 2026, FinanceWire This article has been disseminated on behalf of Quantum BioPharma Ltd. and ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-cse-qntm-advances-ms-imaging-study-with-encouraging-preliminary-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-cse-qntm-advances-ms-imaging-study-with-encouraging-preliminary-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQ","LU2357305700.SGD","FTEC","JEPQ","QDTE","TQQY","LU1244550577.SGD",".IXIC","LU0158827948.USD","BK4516","SQQQ","QQQE","KBWB","MNQmain","LU0795875169.SGD","LU1720051108.HKD","LU1988902786.USD","LU1363072403.SGD","LU0390134368.USD","TECS","IAI","QQQY","TQQQ","IYW","LU1548497426.USD","LU0320765646.SGD","QQQJ","LU0225283273.USD","LU1244550494.USD","LU1989772840.SGD","NQmain","QNTM","ONEQ","GPIQ","LU0053666078.USD","LU2487616109.SGD","QQQM","LU2133065610.SGD","QLD","BK4588","NDX","LU2111349929.HKD","BK4581","PSQ","QYLG","LU0106831901.USD","QID","LU1244550221.USD","NVIW.SI","QQQA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656392686","title":"Quantum Biopharma Ltd Expected to Post a Loss of 42 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656392686","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656392686?lang=en_us&edition=fundamental","pubTime":"2026-08-01 07:13","pubTimestamp":1785539592,"startTime":"0","endTime":"0","summary":"Quantum Biopharma Ltd <QNTM.CD> expected to post a loss of42cents a share - Earnings PreviewQuantum Biopharma LtdQNTM.CDis expected to  show no change in quarterly revenue when it reports  results on August 4  for the period ending June 30 2026LSEG's mean analyst estimate for Quantum Biopharma Ltd is for a loss of 42 cents per share.The one available analyst rating on the shares is \"buy\".The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Quantum Biopharma Ltd is $12.50, about 332.5% above its last closing price of $2.89This summary was machine generated July 31 at 23:13 GMT.  All figures in US dollars unless otherwise stated.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X3H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","QNTM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}]}}